interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Maribavir

Generic competition · all medicines · read 12 November 2026

Is there a generic of Maribavir, and who makes it?

Maribavir appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Maribavir1 dosage-form group in the Orange Book
0generic makers listed
  1. Maribavir appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Livtencity. No generic is listed as marketed.

20202025203020352040204501brand 2021data datePatent 12447169 listed to expire 27 October 2031Patent 12661368 listed to expire 27 October 2031Patent 11684632 listed to expire 4 January 2032Patent 12447170 listed to expire 18 November 2042Patent 12213989 listed to expire 18 November 2042Patent 12433907 listed to expire 18 November 2042Patent 12527771 listed to expire 11 October 2043Patent 12295940 listed to expire 11 October 2043Exclusivity NCE to 23 November 2026Exclusivity ODE-388 to 23 November 2028
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 23 November 2026Exclusivity NCE Livtencity
  • 23 November 2028Exclusivity ODE-388 Livtencity
  • 27 October 2031Patent 12447169
  • 27 October 2031Patent 12661368
  • 4 January 2032Patent 11684632
  • 18 November 2042Patent 12447170
  • 18 November 2042Patent 12213989
  • 18 November 2042Patent 12433907
  • 11 October 2043Patent 12527771 drug substance
  • 11 October 2043Patent 12295940 drug substance

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.